Bortesoha 3.5mg

Bortesoh 3.5 mg refers to a formulation of bortezomib, a proteasome inhibitor used in cancer therapy. Although bortezomib is most commonly available as an injectable (IV or subcutaneous) medication, some brands may be described differently in listings; clinically, it is not a standard oral tablet. Bortezomib works by inhibiting the proteasome, a cellular complex responsible for breaking down proteins. This leads to accumulation of damaged proteins inside cancer cells, triggering cell death. It is primarily used in the treatment of Multiple Myeloma and Mantle Cell Lymphoma. Treatment is given in cycles under strict medical supervision, often in combination with other anticancer drugs. Dosage depends on body surface area and patient response. Common side effects include fatigue, nausea, diarrhea, low blood counts, and peripheral neuropathy (nerve damage causing tingling or numbness). More serious risks include infections and low platelet levels. Because of its potency and potential side effects, Bortesoh (bortezomib) should only be administered by qualified healthcare professionals in a controlled clinical setting.

Price: Rs. 41733.00

• Manufacturer
  A.J.MIRZA PHARMA(Pvt) Ltd
• Generic name
  Bortezomib
• Pack size
  1 Vial injection
• Availability
  In stock
• Prescription required
  Yes